50% off Premium Yearly
Recently on a downward trend. Fundamentally scores 3/10. Would not recommend buying. Price target falling. Has not been able to beat earnings. Better options available for investors. High debt levels not good for dividend outlook.
Stock price when the opinion was issued
As of Aug 19, 2026. Market Open.
Spun off from Merck two years, but has been sitting in the penalty box. Pays a 5.5% dividend at 5x earnings.
It has no growth.
Build your watch list
Sign in to track investmentsyou care about
Baskin Wealth Management
Murray Wealth Group
Stockchase Premium
CNBC
ETF Capital Management Inc.
Recently on a downward trend. Fundamentally scores 3/10. Would not recommend buying. Price target falling. Has not been able to beat earnings. Better options available for investors. High debt levels not good for dividend outlook.